Nasdaq · Healthcare
SIGA TECHNOLOGIES INC (SIGA)
As-reported financials and recent SEC filings for SIGA TECHNOLOGIES INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$94.6M
Net income
$23.3M
Net margin
24.6%
Diluted EPS
$0.32
ROE
11.7%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $94.6M | $138.7M | $139.9M | $110.8M | $133.7M |
| Gross profit | $64.9M | $107.4M | $122.1M | $100.3M | $117.1M |
| Operating income | $23.7M | $70.0M | $83.6M | $42.7M | $89.1M |
| Net income | $23.3M | $59.2M | $68.1M | $33.9M | $69.5M |
| Diluted EPS | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
S-82026-06-25
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →42026-06-10
View on EDGAR →Largest Healthcare peers
Go deeper on SIGA
Search SIGA TECHNOLOGIES INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.